Treatment and recurrence of giant cell tumors of bone - A retrospective cohort from a developing country.

ABSTRACT:

Introduction

GCT is a benign primary bone tumor which is known to cause local recurrence as well as distant metastases. The standard care of treatment of GCT in our institution is the extended intralesional curettage followed by the use bone cement and either phenol or alcohol as adjunct therapy. This offers preservation of joint closest to tumor and decreased risk of recurrence compared to curettage alone. Therefore, the objective of this study was to assess the recurrence of GCT of the bone and time of recurrence-free survival after primary surgery (curettage with adjunct therapy) and determine the influence of factors like site of tumor involvement and demographic factors on the risk of recurrence.

Methods

Non-funded, non-commercial single group retrospective cohort study

SUBMITTER: Hasan O 

PROVIDER: S-EPMC6820075 | biostudies-literature | 2019 Dec

REPOSITORIES: biostudies-literature